Publicaciones en las que colabora con BEATRIZ GARCÍA FONTANA (47)

2024

  1. Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  2. Diabetic bone disease: Metabolic and microvascular damage

    Chronic Complications of Diabetes Mellitus: Current Outlook and Novel Pathophysiological Insights (Elsevier), pp. 173-184

  3. Mild hypophosphatasia may be twice as prevalent as previously estimated: an effective clinical algorithm to detect undiagnosed cases

    Clinical Chemistry and Laboratory Medicine, Vol. 62, Núm. 1, pp. 128-137

  4. Non-Classical Effects of FGF23: Molecular and Clinical Features

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

2023

  1. Analysis of the Genetic Relationship between Atherosclerosis and Non-Alcoholic Fatty Liver Disease through Biological Interaction Networks

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  2. Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Do patients with type 2 diabetes have impaired hip bone microstructure? A study using 3D modeling of hip dual-energy X-ray absorptiometry

    Frontiers in Endocrinology, Vol. 13

  4. Influence of the Mediterranean Diet on Healthy Aging

    International Journal of Molecular Sciences, Vol. 24, Núm. 5

  5. Systemic effects of hypophosphatasia characterization of two novel variants in the ALPL gene

    Frontiers in Endocrinology, Vol. 14

  6. The Influence of the Mediterranean Dietary Pattern on Osteoporosis and Sarcopenia

    Nutrients, Vol. 15, Núm. 14

  7. Vitamin D and COVID-19: where are we now?

    Postgraduate Medicine, Vol. 135, Núm. 3, pp. 195-207

2022

  1. Characterization of Genetic Variants of Uncertain Significance for the ALPL Gene in Patients With Adult Hypophosphatasia

    Frontiers in Endocrinology, Vol. 13

  2. Evaluation of Quality and Bone Microstructure Alterations in Patients with Type 2 Diabetes: A Narrative Review

    Journal of Clinical Medicine, Vol. 11, Núm. 8

  3. Exploring the Role of Sclerostin as a Biomarker of Cardiovascular Disease and Mortality: A Scoping Review

    International Journal of Environmental Research and Public Health, Vol. 19, Núm. 23

  4. Fuerza muscular como predictora de fragilidad ósea en pacientes con diabetes mellitus tipo 2

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 4, pp. 137-144

  5. Genetic relationship between pulmonary diseases of environmental or occupational origin and osteoporosis: a bioinformatic approach

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 4, pp. 130-136

  6. Identification of Potential Targets Linked to the Cardiovascular/Alzheimer’s Axis through Bioinformatics Approaches

    Biomedicines, Vol. 10, Núm. 2

  7. Obesity and Bone Health: A Complex Relationship

    International journal of molecular sciences, Vol. 23, Núm. 15

  8. The Contribution of Wnt Signaling to Vascular Complications in Type 2 Diabetes Mellitus

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  9. Undercarboxylated Osteocalcin: A Promising Target for Early Diagnosis of Cardiovascular and Glycemic Disorders in Patients with Metabolic Syndrome: A Pilot Study

    Nutrients, Vol. 14, Núm. 14